期刊
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 45, 期 2, 页码 199-213出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1040-8428(01)00210-4
关键词
nasopharynx; chemotherapy; radiotherapy
Nasopharyngeal cancer (NPC) is quite rare throughout Europe, accounting for an annual incidence rate below I per 100.000, whereas the highest risk area is South East Asia. A predominant occurrence in males is to be noted. NPC is an etiologically multifactorial disease, most probably involving viral, genetic and environmental factors. Carcinomas of the nasopharynx can be divided into two major histotypes: keratinizing squamous cell carcinomas (WHO-type 1) and non-keratinizing carcinomas (WHO-type 2). The histological type is a prognostic factor and it has a clear impact on the outcome of treatment. Standard therapeutic option for early stages of NPC is radiation, while an integration of radiation therapy and chemotherapy is indicated in more advanced stages. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据